Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations

RL Atmar, WA Keitel, SM Patel, JM Katz… - Clinical infectious …, 2006 - academic.oup.com
Abstract Background. Influenza A/H9N2 viruses can infect humans and are considered to be
a pandemic threat. Effective vaccines are needed for these and other avian influenza …

Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases

AK Shakya, KS Nandakumar - Journal of the Royal …, 2013 - royalsocietypublishing.org
Polymers as an adjuvant are capable of enhancing the vaccine potential against various
infectious diseases and also are being used to study the actual autoimmune responses …

Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults

IF Cook, I Barr, G Hartel, D Pond, AW Hampson - Vaccine, 2006 - Elsevier
In many countries there is no clear recommendation regarding the preferred route of
administration of inactivated influenza vaccines. In a randomised, observer blind study of …

Cancer immunotherapy and nanomedicine

WY Sheng, L Huang - Pharmaceutical research, 2011 - Springer
The immune system has the ability to recognize and kill pre-cancer and cancer cells.
However, with the immune system's surveillance, the survival tumor cells learn how to …

The importance of complying with vaccination protocols in developed countries:“Anti-Vax” hysteria and the spread of severe preventable diseases

F Pandolfi, L Franza, L Todi, V Carusi… - Current Medicinal …, 2018 - ingentaconnect.com
Background: Vaccines are very effective medical tools for disease prevention and life span
increase. Controversies have raised concern about their safety, from autism to polio vaccine …

Influenza vaccines: recent advances in production technologies

N Bardiya, JH Bae - Applied microbiology and biotechnology, 2005 - Springer
In spite of ongoing annual vaccination programs, the seasonal influenza epidemics remain a
major cause of high morbidity and mortality. The currently used “inactivated” vaccines …

Antibody response against heterogeneous circulating influenza virus strains elicited by MF59-and non-adjuvanted vaccines during seasons with good or partial …

F Ansaldi, M Zancolli, P Durando, E Montomoli… - Vaccine, 2010 - Elsevier
MF59 is already known to enhance the breadth of antibody response to mismatched
influenza seasonal and avian strains. However, little is known on the effect of MF59 on …

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus …

G Del Giudice, AK Hilbert, R Bugarini, A Minutello… - Vaccine, 2006 - Elsevier
To test whether inactivated influenza vaccines distributed during the 2003–2004 influenza
season in the northern hemisphere were able to confer protection against the mismatched …

Induction of lupus autoantibodies by adjuvants

M Satoh, Y Kuroda, H Yoshida, KM Behney… - Journal of …, 2003 - Elsevier
Exposure to the hydrocarbon oil pristane induces lupus specific autoantibodies in non-
autoimmune mice. We investigated whether the capacity to induce lupus-like autoimmunity …

[HTML][HTML] Inflammasomes as targets for adjuvants

K Ivanov, E Garanina, A Rizvanov, S Khaiboullina - Pathogens, 2020 - mdpi.com
Inflammasomes are an essential part of the innate immune system. They are necessary for
the development of a healthy immune response against infectious diseases. Inflammasome …